Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages
- PMID: 7717130
- DOI: 10.1007/978-3-7091-9371-6_5
Intrinsic and extrinsic characteristics of human tumors relevant to radiosurgery: comparative cellular radiosensitivity and hypoxic percentages
Abstract
We have collected the in vitro x-ray radiation survival characteristics of 181 lines from 12 different classes of exponentially growing human tumor cells (sarcomas, lung cancers, colo-rectal cancers, medulloblastomas, melanoma, breast cancers, prostate cancers, renal cell cancers, grades III and IV brain tumors, ovarian, and head and neck cancers). This information was used to intercompare survival after single high doses of 20-40 Gy for each tumor line. Radiosensitivities could roughly be divided into two groups. The more radiosensitive group included: sarcoma, small-cell lung cancer, non-small cell lung cancer, colorectal cancer, medulloblastoma and melanoma. The more radioresistant group included breast, prostate, renal cell, primary brain tumors, ovarian tumors, and head and neck cancers. Using a model of a 3 cm diameter brain lesion containing about 1.4 x 10(9) oxic cells, the single doses calculated to reduce survival to 1 cell were: sarcoma and small cell lung cancers-22-23 Gy; melanoma-25 Gy; non-small cell lung and colorectal cancer-26 Gy; medullo-blastoma-28 Gy; breast, prostate, renal cell, primary brain tumors, ovarian tumors, and head and neck cancers-30-36 Gy. If, however, tumors contained on average 20 percent hypoxic cells, the dose needed for equivalent cell killing increased by about a factor of 2.6-2.8. Also, there was no correlation between the ranking of relative radiosensitivities of the various classes of tumor cells at high doses (as in radiosurgery) to the sensitivity at low doses (as in conventional fractionated radiotherapy).
Conclusion: available information on the intrinsic radiosensitivity of human tumor cells indicates that meaningful differences exist among different histological classes of neoplasm that are relevant to the single high doses used in radioneurosurgery, and which could constitute a basis for "tailoring" the administered dose to the particular neoplasm. However, if intracerebral lesions contain a large number of hypoxic cells (e.g., 20%), this may constitute a significant problem.
Similar articles
-
Radiobiological studies of PC-3 and DU-145 human prostate cancer cells: x-ray sensitivity in vitro and hypoxic fractions of xenografted tumors in vivo.Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):283-7. doi: 10.1016/0360-3016(93)90350-5. Int J Radiat Oncol Biol Phys. 1993. PMID: 8420876
-
Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.Cancer. 1997 Dec 15;80(12 Suppl):2519-28. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2519::aid-cncr26>3.3.co;2-t. Cancer. 1997. PMID: 9406705
-
Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.J Neurosurg. 2017 Mar;126(3):735-743. doi: 10.3171/2016.3.JNS153014. Epub 2016 May 27. J Neurosurg. 2017. PMID: 27231978
-
A quantitative overview of radiosensitivity of human tumor cells across histological type and TP53 status.Int J Radiat Biol. 2008 Apr;84(4):253-64. doi: 10.1080/09553000801953342. Int J Radiat Biol. 2008. PMID: 18386191 Review.
-
Radiosensitivity of human cell lines to small doses. Are there some clinical implications?Radiat Res. 1994 Apr;138(1 Suppl):S25-7. Radiat Res. 1994. PMID: 8146319 Review.
Cited by
-
The confluence of stereotactic ablative radiotherapy and tumor immunology.Clin Dev Immunol. 2011;2011:439752. doi: 10.1155/2011/439752. Epub 2011 Nov 15. Clin Dev Immunol. 2011. PMID: 22162711 Free PMC article. Review.
-
Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):166-72. doi: 10.1016/j.ijrobp.2015.05.016. Epub 2015 May 16. Int J Radiat Oncol Biol Phys. 2015. PMID: 26279032 Free PMC article.
-
Stereotactic Radiation Therapy of Single Brain Metastases: A Literature Review of Dosimetric Studies.Cancers (Basel). 2023 Aug 2;15(15):3937. doi: 10.3390/cancers15153937. Cancers (Basel). 2023. PMID: 37568753 Free PMC article. Review.
-
Management of breast cancer brain metastases: Focus on human epidermal growth factor receptor 2-positive breast cancer.Chronic Dis Transl Med. 2017 Mar 8;3(1):21-32. doi: 10.1016/j.cdtm.2017.01.004. eCollection 2017 Mar 25. Chronic Dis Transl Med. 2017. PMID: 29063053 Free PMC article. Review.
-
Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care.Nat Rev Clin Oncol. 2025 May;22(5):327-347. doi: 10.1038/s41571-025-01013-1. Epub 2025 Mar 19. Nat Rev Clin Oncol. 2025. PMID: 40108412 Review.